Anti-cancer effect of danshen and dihydroisotanshinone I on prostate cancer: targeting the crosstalk between macrophages and cancer cells via inhibition of the STAT3/CCL2 signaling pathway

Published 2017 View Full Article

Authors

Keywords

dihydroisotanshinone I, STAT3, prostate cancer, Skp2, CCL2

Journal

Oncotarget

Volume 8, Issue 25, Pages -

Publisher

Impact Journals, LLC

Online

2017-02-02

DOI

10.18632/oncotarget.14958

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started